Viewing Study NCT06818305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-06-14 @ 7:04 AM
Study NCT ID: NCT06818305
Status: TERMINATED
Last Update Posted: 2025-12-11
First Post: 2025-01-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
Sponsor: Jinling Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma (Kidney Cancer) View
None Renal Cell Carcinoma (RCC) View
None Nephrectomy View
None Chronic Kidney Disease(CKD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal Cell Carcinoma View
None Radical Nephrectomy View
None Chronic Kidney Disease View
None Renal Functional Compensation View
None Finerenone View
None Empagliflozin View
None Renal Protection View
None Clinically Significant CKD View
None Randomized Controlled Trial View
None Mineralocorticoid Receptor Antagonist View
None CKD View
None RCC View
None MRA View
None csCKD View
None RCT View